Blankinship & Foster’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Buy |
15,484
+65
| +0.4% | +$12.1K | 0.67% | 17 |
|
|
2025
Q1 | $3.23M | Sell |
15,419
-150
| -1% | -$31.4K | 0.82% | 17 |
|
|
2024
Q4 | $2.77M | Hold |
15,569
| – | – | 0.68% | 17 |
|
|
2024
Q3 | $3.07M | Hold |
15,569
| – | – | 0.75% | 16 |
|
|
2024
Q2 | $2.67M | Hold |
15,569
| – | – | 0.69% | 15 |
|
|
2024
Q1 | $2.84M | Sell |
15,569
-143
| -0.9% | -$26K | 0.74% | 15 |
|
|
2023
Q4 | $2.43M | Buy |
15,712
+144
| +0.9% | +$22.3K | 0.69% | 15 |
|
|
2023
Q3 | $2.32M | Buy |
15,568
+193
| +1% | +$28.8K | 0.77% | 13 |
|
|
2023
Q2 | $2.07M | Buy |
15,375
+353
| +2% | +$47.6K | 0.67% | 14 |
|
|
2023
Q1 | $2.39M | Buy |
15,022
+289
| +2% | +$46.1K | 1.04% | 13 |
|
|
2022
Q4 | $2.38M | Hold |
14,733
| – | – | 1.04% | 16 |
|
|
2022
Q3 | $1.98M | Sell |
14,733
-100
| -0.7% | -$13.4K | 0.96% | 15 |
|
|
2022
Q2 | $2.27M | Buy |
14,833
+750
| +5% | +$115K | 1.05% | 13 |
|
|
2022
Q1 | $2.28M | Sell |
14,083
-148
| -1% | -$24K | 0.92% | 16 |
|
|
2021
Q4 | $1.93M | Sell |
14,231
-558
| -4% | -$75.6K | 0.73% | 20 |
|
|
2021
Q3 | $1.6M | Hold |
14,789
| – | – | 0.65% | 20 |
|
|
2021
Q2 | $1.67M | Hold |
14,789
| – | – | 0.66% | 19 |
|
|
2021
Q1 | $1.6M | Hold |
14,789
| – | – | 0.67% | 20 |
|
|
2020
Q4 | $1.59M | Hold |
14,789
| – | – | 0.66% | 19 |
|
|
2020
Q3 | $1.3M | Buy |
+14,789
| New | +$1.3M | 0.62% | 20 |
|